GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
Status:
Withdrawn
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of GS-6615 in adults with chronic stable angina and
coronary artery disease (CAD) receiving a stable daily dose of up to 2 antianginal
medications. The study will consist of two periods: a 1 to 3 week Qualifying Period and a
Treatment Period lasting 13 days (± 3 days). During the Qualifying Period and at the end of
the Treatment Period, participants will undergo exercise tolerance testing.